Search Results 91-100 of 16605 for villous atrophy
A Study to Create a Diagnostic Test for Patients with Parkinson's disease, Multiple System Atrophy, Dementia with Lewy bodies and Pure Autonomic Failure.
Cunningham R, Badihian N, Chou C, Jackson L, Rhee L, Coon E. Neuropalliative Care Symptoms and Distress in Patients with Multiple System Atrophy (P1-7.001).
The purpose of this study is to evaluate the effectiveness of Lu AF82422 on disease progression in patients with Multiple System Atrophy (MSA). Participation ...
The U.S. Food and Drug Administration (FDA) has approved gene therapy products for several conditions, including cancer, spinal muscular atrophy, hemophilia and ...
By comparing the gene expression of motor neurons derived from iPSC cells of phenotypically discordant Spinal Muscular Atrophy (SMA) sibling pairs and ...
A Study to Evaluate Sex and Gender in Multiple System Atrophy ... Atrophy (MSA) in order to determine sex-specific hormonal factors associated ...
Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) · Overview · Participation eligibility · Participating Mayo Clinic ...
The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at early clinical ...
Dr. Wszolek: So whole exome sequencing allowed us to make the diagnosis precisely and quickly. Dustin suffers from a condition called episodic ataxia. This is a ...
The purpose of this study is to validate use of a modified Unified Multiple System Atrophy Rating Scale (UMSARS) that incorporates structured questions and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.